3651 results for «301»

Filter By

3651 results

Uncommon causes of coronary ischaemia: expect the unexpected!

06 Dec 2023 – From GulfPCR-GIM 2023

Broaden your knowledge and learn about unusual causes of coronary ischaemia. Explore a variety of cases, including the discovery of a coronary fistula, how to diagnose coronary subclavian steal syndrome (CSSS), and more!

PCR London Valves 2023 EAPCI Awards Ceremony

21 Nov 2023 – From PCR London Valves 2023

Discover the winners of the EAPCI Awards in this ceremony jointly presented by Emanuele Barbato, EAPCI President, and Tanja Rudolph, Co-Chair of the EAPCI Fellowship Grants Committee. While 14 nominees were shortlisted, seven had already been honored at EuroPCR 2023: Find out who the lucky winners...

EAPCI Awards Ceremony

Nightmare in the cathlab

06 Dec 2023 – From GulfPCR-GIM 2023

These presentations focus on complications that may occur during PCI in the cathlab. Through the lens of these cases, be prepared about what type of complications one might face during PCI, and get updates on the latest guidelines and tools developed for emergencies.

PCR London Valves 2023 Closing Ceremony

21 Nov 2023 – From PCR London Valves 2023

Experience the highlights of PCR London Valve 2023 in this video retrospective, followed by insights from the Course Directors as they reflect on 3 dynamic and fruitful days that united 3,700 participants. Gratitude is extended to all contributors whose support was instrumental in the event's success....

PCR London Valves 2023 Closing Ceremony

Interventional cardiologists in the space of peripheral arterial disease: when and why

06 Dec 2023 – From GulfPCR-GIM 2023

How do interventional cardiologists deal with the burden of peripheral arterial disease in the Gulf region? Review the basic tool box for peripheral intervention and learn how to overcome daily challenges in structural cases.

Challenging CTO interventions: part 2

06 Dec 2023 – From GulfPCR-GIM 2023

Keep learning about challenging cases of CTO interventions in the continuation of this session. Discover how IVUS may be used to better guide intervention, gain insight into the use of the knuckle wire technique as a last resort during difficult cases, and learn how to deal...

Rapid-fire - Combined mitral and tricuspid procedures

20 Nov 2023 – From PCR London Valves 2023

Leaflet modification techniques

20 Nov 2023 – From PCR London Valves 2023

Discover cutting-edge leaflet modification approaches in transcatheter interventions with this selection of cases: explore the imaging aspects of the emerging ShortCut procedure for coronary protection in Valve-in-Valve TAVR, experience the effectiveness and simplicity of Balloon - Basilica for valve-in-valve interventions, learn about the adaptability of right...

Leaflet modification techniques

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative MR and Complex Mitral Valve Anatomy

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...

Paola Redaelli

Author

Paola Redaelli
M. Pighi

Author

Michele Pighi
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
Didn’t find what you were looking for?